[HTML][HTML] Oral spironolactone for acne vulgaris in adult females: a hybrid systematic review

AM Layton, EA Eady, H Whitehouse… - American journal of …, 2017 - Springer
Background The management of acne in adult females is problematic, with many having a
history of treatment failure and some having a predisposition to androgen excess …

[PDF][PDF] European evidence-based (S3) guidelines for the treatment of acne.

A Nast, B Dreno, V Bettoli, K Degitz… - Journal of the …, 2012 - academia.edu
An evidence-based guideline has been defined as 'a systematically developed statement
that assists clinicians and patients in making decisions about appropriate treatment for a …

[HTML][HTML] A Review of hormone-based therapies to treat adult acne vulgaris in women

MK Trivedi, K Shinkai, JE Murase - International journal of women's …, 2017 - Elsevier
Hormone-based therapies including combined oral contraceptive medications and
spironolactone are considered effective therapies to treat adult acne in women. Our …

Can sebum reduction predict acne outcome?

N Janiczek‐Dolphin, J Cook, D Thiboutot… - British Journal of …, 2010 - academic.oup.com
Sebum excretion has generally been accepted as an important factor in the development of
acne vulgaris. However, the relationship of sebum excretion and acne outcome has not yet …

A comparison of multiphasic oral contraceptives containing norgestimate or desogestrel in acne treatment: a randomized trial

U Jaisamrarn, S Chaovisitsaree, S Angsuwathana… - Contraception, 2014 - Elsevier
Objective This study aimed to compare the effectiveness and safety of triphasic combined
oral contraceptives (OCs) containing ethinyl estradiol (EE) and norgestimate (NGM) and …

Unmet needs in the management of acne vulgaris: a consensus statement

H Baldwin, A Farberg, C Frey… - Journal of drugs in …, 2023 - pubmed.ncbi.nlm.nih.gov
Acne vulgaris is the most common skin condition in the US, affecting up to 50 million
Americans. The American Academy of Dermatology (AAD) guidelines on acne treatment …

Drug safety evaluation of desogestrel

C Scala, U Leone Roberti Maggiore… - Expert opinion on …, 2013 - Taylor & Francis
Introduction: Desogestrel (DSG) is a third-generation progestin. It is commonly used in
various formulations for hormonal contraception including combinations with ethinyl …

[HTML][HTML] Менеджмент побочных эффектов в стратегии повышения приверженности к комбинированным оральным контрацептивам. Роль трехфазного …

ГБ Дикке - Акушерство, гинекология и репродукция, 2022 - cyberleninka.ru
Введение. Побочные эффекты при приеме комбинированных оральных
контрацептивов (КОК) являются причиной отказов от приема КОК женщинами во всем …

Современный взгляд на использование гормональной контрацепции у подростков

АД Зернюк - Гинекология, 2006 - elibrary.ru
Частота беременностей у подростков за последние 20 лет возросла во многих странах
в связи с рядом факторов и имеет выраженную тенденцию к дальнейшему …

[HTML][HTML] Control of side effects in strategy for increasing adherence to combined oral contraceptives. The role for a three-phase desogestrel-containing drug

GB Dikke - Obstetrics, Gynecology and Reproduction, 2022 - gynecology.su
Introduction. The frequency of side effects when taking combined oral contraceptives
(COCs) is still high, which is the reason for refusal to take COCs by women worldwide with a …